NCT02061800 2024-06-04
CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
Columbia University
Phase 1/2 Active not recruiting
Columbia University
Universitätsklinikum Hamburg-Eppendorf
West Virginia University
Chelsea and Westminster NHS Foundation Trust
Memorial Sloan Kettering Cancer Center